These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 11533525)
1. The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular diseases. Neagu M; Manda G; Constantin C; Tanaseanu C; Mikhailidis DP Int Angiol; 2001 Jun; 20(2):164-73. PubMed ID: 11533525 [TBL] [Abstract][Full Text] [Related]
2. Tolerability of percutaneous coronary interventions in patients receiving nadroparin calcium for unstable angina or non-Q-wave myocardial infarction: the Angiofrax study. Bassand JP; Berthe C; Bethencourt A; Bolognese L; Wójcik J; Curr Med Res Opin; 2003; 19(2):107-13. PubMed ID: 12740154 [TBL] [Abstract][Full Text] [Related]
3. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice]. Ottani F; Ferrini D; Di Pasquale G; Galvani M Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833 [TBL] [Abstract][Full Text] [Related]
4. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of clot formation process by treatment with the low-molecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting. A thromboelastography study on whole blood. Konstantinidis K; Gerasimidis T; Verdy E; Elalamy I; Samama MM; Gerotziafas GT Thromb Haemost; 2007 Jan; 97(1):109-18. PubMed ID: 17200777 [TBL] [Abstract][Full Text] [Related]
8. Suppression of membrane microvesiculation--a possible anticoagulant and anti-tumor progression effect of heparin. Sustar V; Jansa R; Frank M; Hagerstrand H; Krzan M; Iglic A; Kralj-Iglic V Blood Cells Mol Dis; 2009; 42(3):223-7. PubMed ID: 19261492 [TBL] [Abstract][Full Text] [Related]
9. The effect of low molecular weight heparin on survival in patients with advanced malignancy. Klerk CP; Smorenburg SM; Otten HM; Lensing AW; Prins MH; Piovella F; Prandoni P; Bos MM; Richel DJ; van Tienhoven G; Büller HR J Clin Oncol; 2005 Apr; 23(10):2130-5. PubMed ID: 15699479 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials. De Luca G; Marino P Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079 [TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403 [TBL] [Abstract][Full Text] [Related]
12. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke. Sarma GR; Roy AK Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005 [TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H; Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829 [TBL] [Abstract][Full Text] [Related]
14. Iatrogenic calcinosis cutis following nadroparin injection. Giorgini S; Martinelli C; Massi D; Lumini A; Mannucci M; Giglioli L Int J Dermatol; 2005 Oct; 44(10):855-7. PubMed ID: 16207189 [TBL] [Abstract][Full Text] [Related]
16. In vitro anticoagulation monitoring of low-molecular-weight heparin. Wang JQ; Shi XB; Yang JG; Hu DY Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471 [TBL] [Abstract][Full Text] [Related]
17. Investigation of direct toxic and teratogenic effects of anticoagulants on rat embryonic development using in vitro culture method and genotoxicity assay. Uysal II; Karabulut AK; Ozdemir K; Aksoy M; Altunkeser BB; Acar H Anat Histol Embryol; 2006 Apr; 35(2):84-92. PubMed ID: 16542172 [TBL] [Abstract][Full Text] [Related]